Evidence map›Paper›PMID 38005822›Full record

ArticleViruses2023

Discovery of a Novel Intron in US10/US11/US12 of HSV-1 Strain 17.

Weizhong Chang, Ming Hao, Ju Qiu, Brad T Sherman, Tomozumi Imamichi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Weizhong ChangLaboratory of Human Retrovirology and Lmmunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.ORCID 0000-0002-1413-2763
Ming HaoLaboratory of Human Retrovirology and Lmmunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Ju QiuLaboratory of Human Retrovirology and Lmmunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Brad T ShermanLaboratory of Human Retrovirology and Lmmunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Tomozumi ImamichiLaboratory of Human Retrovirology and Lmmunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.ORCID 0000-0002-1474-1796
Frederick National Laboratory for Cancer Research · US

Funding

CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Herpes Simplex Virus type 1 (HSV-1) infects humans and causes a variety of clinical manifestations. Many HSV-1 genomes have been sequenced with high-throughput sequencing technologies and the annotation of these genome sequences heavily relies on the known genes in reference strains. Consequently, the accuracy of reference strain annotation is critical for future research and treatment of HSV-1 infection. In this study, we analyzed RNA-Seq data of HSV-1 from NCBI databases and discovered a novel intron in the overlapping coding sequence (CDS) of

Indexed as

Herpesvirus 1, HumanIntronsViral ProteinsBase SequenceHerpes SimplexHumansViral Proteinsgene annotationHSV-1novel intronUS10US11US12virus gene

Identifiers

PMID38005822
PMCPMC10675037
OpenAlexW4387939923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.